The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Signal Transduction | Immunology
The EMBO Journal (2005) 24, 3423–3434, doi:10.1038/sj.emboj.7600807
Published online 15 September 2005
Inhibitor of apoptosis 2 and TAK1-binding protein are components of the Drosophila Imd pathway
Anni Kleino1, 8, Susanna Valanne1, 8, Johanna Ulvila2, 3, Jenni Kallio1, Henna Myllymäki1, Heidi Enwald2, 3, Svenja Stöven4, Mickael Poidevin5, Ryu Ueda6, Dan Hultmark4, Bruno Lemaitre5 and Mika Rämet1, 2, 3, 7
1 Institute of Medical Technology, University of Tampere, Tampere, Finland
2 Department of Pediatrics, University of Oulu, Oulu, Finland
3 Biocenter Oulu, Oulu, Finland
4 Umeå Centre for Molecular Pathogenesis, Umeå University, Umeå, Sweden
5 Centre de Génétique Moléculaire, CNRS, Gif-sur-Yvette, France
6 Genetic Strains Research Center, National Institute of Genetics, Shizuoka, Japan
7 Department of Pediatrics, Tampere University Hospital, Tampere, Finland

To whom correspondence should be addressed
Mika Rämet, Institute of Medical Technology, University of Tampere, Tampere 33014, Finland. Tel.: +358 3 35518593; Fax: +358 3 35517710; E-mail: mika.ramet@uta.fi

8 These authors contributed equally to this work

Received 17 June 2005; Accepted 17 August 2005; Published online 15 September 2005.
Abstract
The Imd signaling cascade, similar to the mammalian TNF-receptor pathway, controls antimicrobial peptide expression in Drosophila. We performed a large-scale RNAi screen to identify novel components of the Imd pathway in Drosophila S2 cells. In all, 6713 dsRNAs from an S2 cell-derived cDNA library were analyzed for their effect on Attacin promoter activity in response to Escherichia coli. We identified seven gene products required for the Attacin response in vitro, including two novel Imd pathway components: inhibitor of apoptosis 2 (Iap2) and transforming growth factor-activated kinase 1 (TAK1)-binding protein (TAB). Iap2 is required for antimicrobial peptide response also by the fat body in vivo. Both these factors function downstream of Imd. Neither TAB nor Iap2 is required for Relish cleavage, but may be involved in Relish nuclear localization in vitro, suggesting a novel mode of regulation of the Imd pathway. Our results show that an RNAi-based approach is suitable to identify genes in conserved signaling cascades.
Keywords: antimicrobial peptide expression, Drosophila, innate immunity, RNAi screen, signaling
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Immunology Cascade into clarity

Nature News and Views (17 Jan 2008)

Akirins versus infection

Nature Immunology News and Views (01 Jan 2008)

See all 3 matches for News And Views

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2005 by the European Molecular Biology Organization